Chemoinformaics analysis of (E)-13-CYCLOPENT-2-EN-1-YLTRIDEC-6-ENOIC ACID
Molecular Weight | 278.436 | nRot | 12 |
Heavy Atom Molecular Weight | 248.196 | nRig | 13 |
Exact Molecular Weight | 278.225 | nRing | 1 |
Solubility: LogS | -0.972 | nHRing | 0 |
Solubility: LogP | -0.838 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 51.6678 |
nHD | 1 | BPOL | 30.9642 |
QED | 0.456 |
Synth | 3.655 |
Natural Product Likeliness | 1.947 |
NR-PPAR-gamma | 0.017 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.136 |
HIA | 0.897 |
CACO-2 | -5.403 |
MDCK | 0.000283565 |
BBB | 0.715 |
PPB | 0.746939 |
VDSS | 0.59 |
FU | 0.338192 |
CYP1A2-inh | 0.021 |
CYP1A2-sub | 0.11 |
CYP2c19-inh | 0.014 |
CYP2c19-sub | 0.352 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.543 |
CYP2d6-inh | 0.002 |
CYP2d6-sub | 0.319 |
CYP3a4-inh | 0.01 |
CYP3a4-sub | 0.032 |
CL | 1.904 |
T12 | 0.727 |
hERG | 0.054 |
Ames | 0.327 |
ROA | 0.196 |
SkinSen | 0.303 |
Carcinogencity | 0.369 |
EI | 0.012 |
Respiratory | 0.149 |
NR-Aromatase | 0.098 |
Antiviral | Yes |
Prediction | 0.64116 |